Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Siegel Jolie Insider Profile
4 Followers
Siegel Jolie, VP & GC at Neon Therapeutics, holds 0.00 shares in Neon Therapeutics (Ticker: NTGN).
Siegel Jolie Neon Therapeutics (NTGN)VP & GC
Neon Therapeutics (NTGN)
VP & GC
Not Ranked
Siegel Jolie has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Siegel Jolie does not currently own shares as a corporate insider.
A breakdown of Siegel Jolie's holdings
Insider Roles
Siegel Jolie does not currently hold a role as a corporate insider.
Roles that Siegel Jolie holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Siegel Jolie
Siegel Jolie's Trading History
List of latest transactions for each holding click on a transaction to see Siegel Jolie's performance on stock
You May Also Like
Siegel Jolie insider profile FAQ
What is the percentage of profitable transactions made by Siegel Jolie?
The percentage of profitable transactions made by Siegel Jolie is ―.
What is the average return per transaction made by Siegel Jolie?
The average return per transaction made by Siegel Jolie is ―.
What stocks does Siegel Jolie hold?
Siegel Jolie holds: NTGN stocks.
What was Siegel Jolie’s latest transaction?
Siegel Jolie latest transaction was an Uninformative Sell of ―.
What was Siegel Jolie's most profitable transaction?
Siegel Jolie’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Siegel Jolie's role in Neon Therapeutics?
Siegel Jolie's role in Neon Therapeutics is VP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.